0000000000672257
AUTHOR
H. Schroder
Observation of Time-Reversal Violation in the B0 Meson System
Although CP violation in the B meson system has been well established by the B factories, there has been no direct observation of time reversal violation. The decays of entangled neutral B mesons into definite flavor states ($B^0$ or $\bar{B}^0$), and $J/\psi K_S^0$ or $c\bar{c} K_S^0$ final states (referred to as $B_+$ or $B_-$), allow comparisons between the probabilities of four pairs of T-conjugated transitions, for example, $\bar{B}^0 \rightarrow B_-$ and $B_- \rightarrow \bar{B}^0$, as a function of the time difference between the two B decays. Using 468 million $B\bar{B}$ pairs produced in $\Upsilon(4S)$ decays collected by the BABAR detector at SLAC, we measure T-violating parameter…
Changes in bread consumption and 4-year changes in adiposity in Spanish subjects at high cardiovascular risk
Ramón Estruch [et al.]
Measurement of branching fractions and rate asymmetries in the rare decays B -> K((*))l(+)l(-)
In a sample of 471 million BB events collected with the BABAR detector at the PEP-II e+e- collider we study the rare decays B -> K(*) l+ l-, where l+ l- is either e+e- or mu+mu-. We report results on partial branching fractions and isospin asymmetries in seven bins of di-lepton mass-squared. We further present CP and lepton-flavor asymmetries for di-lepton masses below and above the J/psi resonance. We find no evidence for CP or lepton-flavor violation. The partial branching fractions and isospin asymmetries are consistent with the Standard Model predictions and with results from other experiments.
The BaBar detector: Upgrades, operation and performance
The BABAR detector operated successfully at the PEP-Il asymmetric e(+) e(-) collider at the SLAC National Accelerator Laboratory from 1999 to 2008. This report covers upgrades, operation, and performance of the collider and the detector systems, as well as the trigger, online and offline computing, and aspects of event reconstruction since the beginning of data taking.